Mortality and morbidity in patients with congenital heart disease hospitalised for viral pneumonia. Issue 13 (27th October 2020)

• Record Type: Journal Article
• Authors: Diller, Gerhard-Paul; Enders, Dominic; Lammers, Astrid E; Orwat, Stefan; Schmidt, Renate; Radke, Robert M; Gerss, Joachim; De Torres Alba, Fernando; Kaleschke, Gerrit; Bauer, Ulrike M; Marschall, Ursula; Baumgartner, Helmut
• Is Part Of: Heart. Volume 107:Issue 13(2021)
• Page Start: 1069
• Page End: 1076
• Publication Date: 2020-10-27
• Subjects: congenital heart disease; Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2020-317706
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Objectives: Data on the clinical outcome of patients with congenital heart disease (CHD) affected by severe viral pneumonia are limited. We analysed morbidity and mortality of viral pneumonia and evaluated the association between medical conditions, medication, vaccination and outcome specifically in patients with CHD requiring hospitalisation for viral pneumonia. Methods: Based on data from one of Germany's largest health insurers, all cases of viral pneumonia requiring hospital admission (2005–2018) were studied. Mortality, and composites of death, transplantation, mechanical circulatory support, ventilation or extracorporeal lung support served as endpoints. Results: Overall, 26 262 viral pneumonia cases occurred in 24 980 patients. Of these, 1180 cases occurred in patients with CHD. Compared with patients without CHD, mortality rate was elevated in patients with CHD. As a group, patients with CHD aged 20–59 years even exceeded mortality rates in patients without CHD aged >60 years. No mortality was observed in patients with CHD with simple defects <60 years of age without associated cardiovascular risk factors. On multivariable logistic regression analysis, age, CHD complexity, chromosomal anomalies, cardiac medication, use of immunosuppressants and absence of vaccination for influenza emerged as risk factors of adverse outcome. Conclusions: We present timely data on morbidity and mortality of severe viral pneumonia requiring hospital admission in patients with CHD. Need for mechanical ventilation and risk of death in CHD increase early in life, reaching a level equivalent to non-CHD individuals >60 years of age. Our data suggest that except for patients with isolated simple defects, patients with CHD should be considered higher-risk individuals when faced with severe viral pneumonia.